This article explores how in-trial interviews and qualitative research provide deep insights into patient experience data (PED) across multiple timepoints in clinical trials. They enhance patient-centered research and provide value that can be realized through use of the data to support endpoint validation, regulatory submissions, HTA evaluations, and more.